Indivior Pharmaceuticals Inc
USD33.71
-1.17 (-3.35%)
CEO
Joseph J. Ciaffoni
IPO Date
2014-12-29
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$34.33
Prev. Close
$34.88
Day Low
$32.42
Day High
$34.66
52W Low
$12.81
52W High
$41.00
Market Cap
$4.21B
Volume
2.30M
| 6,518 |
| $0.00 |
| 14 May 2026 | Humphreys Keith | director | A-Award | Acquired | 6,518 | $0.00 |
| 14 May 2026 | Kingsley Stuart A | director | A-Award | Acquired | 6,518 | $0.00 |
| 14 May 2026 | NINIVAGGI DANIEL A | director | A-Award | Acquired | 6,518 | $0.00 |
| 14 May 2026 | Ryan Barbara | director | A-Award | Acquired | 6,518 | $0.00 |
| 14 May 2026 | Stejbach Mark | director | A-Award | Acquired | 6,518 | $0.00 |
| 14 May 2026 | Wheadon David E. | director | A-Award | Acquired | 10,430 | $0.00 |
| 17 Mar 2026 | Preblick Ryan | Chief Financial Officer | M-Exempt | Acquired | 6,302 | $0.00 |
| 17 Mar 2026 | Preblick Ryan | Chief Financial Officer | F-InKind | Disposed | 2,843 | $31.11 |